DWC-202203
- Generic Name
- DWC-202203
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
Phase 1
Completed
- Conditions
- Drug Drug Interaction
- Interventions
- First Posted Date
- 2022-10-10
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Target Recruit Count
- 36
- Registration Number
- NCT05574374
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath